HOME >> BIOLOGY >> NEWS
Biodesign and TGen form joint Center for Systems and Computational Biology

To help usher in a new era of molecular diagnostics and personalized medicine, ASU's Biodesign Institute and the Translational Genomics Research Institute (TGen) have teamed up to establish the Center for Systems and Computational Biology.

One of the first of its kind in the nation, the new center will accelerate the pace of biomedical research, directly impact patient care and provide new funding opportunities for both TGen and ASU. George Poste, director of the Biodesign Institute, and Jeffrey Trent, president and scientific director of TGen, will oversee the center. Systems biology is an emerging science that requires highly-integrated efforts between biologists, physicians, chemists, engineers and computer scientists. It combines "wet lab" research with "dry lab" computational technologies to help identify the molecular pathways relevant to disease. The resulting benefits to medicine may include better clinical trials, personalized therapies and improved diagnostics, drugs and vaccines.

"Much of our focus at Biodesign is in trying to understand biological function and the significance of disease at the most fundamental level: its molecular circuitry," said Poste. "This knowledge has enormous implications for every aspect of medicine, as well as other fields of science."

"At TGen, our focus is entirely on developing earlier diagnostics and smarter treatments," said Trent. "This new collaboration leverages the fast-growing field of computational biology to speed research and directly impact patients. Additionally, this partnership opens the door to new research and funding avenues for both TGen and ASU."

Accelerating Research

The Center for Systems and Computational Biology will use the extraordinary power of the ASU-TGen supercomputer to accelerate research by quickly analyzing the billions of data points generated by genetic research. For example, a researcher at a major U.S. university estimated it would take hi
'"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
6-Feb-2006


Page: 1 2 3 4

Related biology news :

1. Biodesign Institute leads innovative project to prevent cancer
2. Biodesign Institute takes part in $14.4M NIH chemical defense grant
3. Biodesign Institute participates in first-of-its-kind coyote disaster preparedness drill
4. Biodesign Institute at ASU named lab of the year in international competition
5. Biodesign Institute awarded $3.2 million to develop vaccine to thwart biothreat
6. Biodesign Institute and TGen awarded grants to help lessen threat of radiological terrorist event
7. New joint replacement material developed at MGH put to first clinical use
8. It takes a village -- female ducks negotiate joint rearing of ducklings
9. Brown and OTS will jointly manage new ILTER network secretariat
10. How movement lubricates bone joints
11. Gene therapy research switches off joint inflammation; switches on genetic process of joint repair

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... ... announced that an extensive third-party assessment of the company’s security practices has been ... against federal security regulations. The comprehensive evaluation reviewed Litmus’ processes and systems, assessing ...
(Date:8/26/2020)... ... August 25, 2020 , ... ... novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company ... U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with ...
(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is ... is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made ... three-year revenue growth of 71 percent. , The Inc. 5000 list represents a ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem cell therapy ... stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or ... some form of Alzheimers dementia, and the incidence continues to increase as individuals live ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
Breaking Biology Technology:
Cached News: